Clinical Trials
7 trialsNCT05927012 2023-11-24
A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).
Keros Therapeutics, Inc.
Phase 2 Withdrawn
NCT04318405 2023-07-19
Real-CHOICE
Pierre Fabre Pharma AG
Completed
NCT01100879 2022-05-09
AOC-MM
Vifor Pharma
Phase 4 Terminated
NCT03924271 2019-04-23
CARENFER ONCO
VIFORFRANCE
Phase NA Unknown
NCT03411590 2018-01-29
GaGA
FrieslandCampina WAMCO Nigeria PLC
Phase NA Unknown
NCT01101399 2013-12-18
FID-CHEMO
Vifor Pharma
Phase 3 Completed
NCT00199277 2005-09-20
Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.
J. Uriach and Company
Phase 4 Unknown